I was happy to see Nature Medicine reporter Monya Baker's article today on efforts to create therapies from induced pluripotent stem cells (or iPS cells). Monya describes the work of Stanford researchers Anthony Oro, MD, PhD; Alfred Lane, MD; and Marius Wernig, MD, to develop a treatment for a devastating childhood skin disorder called epidermolysis bullosa to illustrate the promise of the cells and the pitfalls that must be overcome before moving them into the clinic.
It's a fascinating roundup of research at Stanford and elsewhere. It also illustrates the unique power, collaborative nature and ambitious timeline of 'Disease Teams' funded by the California Institute for Regenerative Medicine.
Previously: Stem cells from ordinary skin may treat rare skin disease
